Late effects - the new focus of follow-up

Christoffer Johansen; Annika von Heymann; Bolette S Rafn; Signe Borgquist; Peer Christiansen; Peter Christensen; Robert Zachariae; Helle Pappot; Ulrik Lassen

doi:10.1080/0284186X.2022.2137845

Late effects - the new focus of follow-up

Christoffer Johansen^*, Annika von Heymann, Bolette S Rafn, Signe Borgquist, Peer Christiansen, Peter Christensen, Robert Zachariae, Helle Pappot, Ulrik Lassen

^*Corresponding author af dette arbejde

Afdeling for Kræftbehandling

5 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Acta Oncologica
Vol/bind	61
Udgave nummer	10
Sider (fra-til)	1163-1164
Antal sider	2
ISSN	0284-186X
DOI	https://doi.org/10.1080/0284186X.2022.2137845
Status	Udgivet - okt. 2022

Adgang til dokumentet

10.1080/0284186X.2022.2137845

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{1f7defcdd5074be8bb5c8b3a322a81e3,

title = "Late effects - the new focus of follow-up",

keywords = "Disease Progression, Follow-Up Studies, Humans, Survivors",

author = "Christoffer Johansen and {von Heymann}, Annika and Rafn, {Bolette S} and Signe Borgquist and Peer Christiansen and Peter Christensen and Robert Zachariae and Helle Pappot and Ulrik Lassen",

year = "2022",

month = oct,

doi = "10.1080/0284186X.2022.2137845",

language = "English",

volume = "61",

pages = "1163--1164",

journal = "Acta Oncologica",

issn = "0284-186X",

publisher = "Medical Journals Sweden AB",

number = "10",

}

TY - JOUR

T1 - Late effects - the new focus of follow-up

AU - Johansen, Christoffer

AU - von Heymann, Annika

AU - Rafn, Bolette S

AU - Borgquist, Signe

AU - Christiansen, Peer

AU - Christensen, Peter

AU - Zachariae, Robert

AU - Pappot, Helle

AU - Lassen, Ulrik

PY - 2022/10

Y1 - 2022/10

KW - Disease Progression

KW - Follow-Up Studies

KW - Humans

KW - Survivors

UR - http://www.scopus.com/inward/record.url?scp=85140824671&partnerID=8YFLogxK

U2 - 10.1080/0284186X.2022.2137845

DO - 10.1080/0284186X.2022.2137845

M3 - Editorial

C2 - 36306149

SN - 0284-186X

VL - 61

SP - 1163

EP - 1164

JO - Acta Oncologica

JF - Acta Oncologica

IS - 10

ER -